Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
- PMID: 32380317
- PMCID: PMC7198424
- DOI: 10.1016/j.autrev.2020.102558
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
Keywords: Coronavirus; Interstitial lung disease; Systemic sclerosis.
Comment on
-
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.
References
-
- Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutiérrez-Ocampo E. Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020:101623. doi: 10.1016/j.tmaid.2020.101623. in press. - DOI - PMC - PubMed
